(B) New H2A.X accumulation at sites of UVC damage (XPA, CPD) revealed 2 h after irradiation in the absence of flavopiridol (-FLV) upon high UVC dose (500 J/m 2 ). Right, confocal images. Percentages of cells accumulating new H2A.X at UV sites are shown on the graph and the enrichment of new H2A.X at UV sites relative to the whole nucleus is presented on the scatter plot (bar: mean; error bars: SD from 99 UV spots; the significance of H2A.X enrichment at UV sites is indicated, compared to a theoretical mean of 1, dotted line). (C) New H2A.X accumulation at sites of UVA laser damage marked by γH2A.X analyzed 2 h after irradiation in U2OS cells stably expressing H2A.X-SNAP. (D) We assessed whether UVC irradiation was triggering a DSB response at the time of new H2A.X deposition by examining the dependency of H2A.X phosphorylation on ATM (ataxia telangiectasia mutated) and ATR kinases using specific inhibitors. ATM is known to phosphorylate H2A.X in response to DSBs. We observed that H2A.X phosphorylation upon local UVC irradiation was strictly ATR-and not ATM-dependent, as opposed to H2A.X phosphorylation following treatment with the DSB-inducing drug neocarzinostatin (NCS), which was strictly ATMdependent: γH2A.X levels at sites of UVC irradiation (top) and upon cell exposure to the DSB-inducing agent neocarzinostatin (NCS) analyzed in U2OS cells treated with the indicated inhibitors (ATMi, ATRi; DMSO, vehicle). UVC-irradiated cells with pan-nuclear γH2A.X upon ATR inhibition (replicative stress, asterisk) were excluded from the analysis. The intensity of γH2A.X signal at UVC damage sites (delineated by XPB staining) and in the nucleus of NCS-treated cells is shown on the scatter plots (bars: mean; error bars: SD from at least 67 UVC spots and 195 NCS-treated cells). Similar results were obtained in three independent experiments and data from one representative experiment are shown. Figure 4D and 5B, except that data were normalized to UV damage levels based on CPD counterstaining and H2A.Z data is presented as %loss at UV sites relative to the nucleus (bar: mean; error bars: SD from at least 84 UV spots). The significance of H2A.Z loss at UV sites is indicated (compared to a theoretical mean of 0%, dotted line). Similar results were obtained in two and three independent experiments, respectively, and data from one representative experiment are shown. (H) Nascent transcription monitored by ethynyl-uridine (EU) incorporation in U2OS H2A.X-SNAP cells treated with the indicated siRNAs (siLUC: control; siFACT: combination of siSPT16 and siSSRP1). The efficiency of FACT knock-down is controlled by western-blot. Quantitation of EU levels in nuclei is shown on the scatter plot (bars: mean; error bars: SD from at least 140 cells). Similar results were obtained in three independent experiments and data from one representative experiment are shown. (I) New H2A accumulation 1h30 after local UVC irradiation in U2OS H2A-SNAP cells treated with the indicated siRNAs (siLUC: control; siFACT: combination of siSPT16 and siSSRP1). Knock-down efficiencies are verified by western-blot. The intensity of new H2A signal (TMR fluorescence) at UV sites and in entire nuclei are shown on the graphs (bars: mean; error bars: SD from at least 150 cells). Similar results were obtained in four independent experiments and data from one representative experiment are shown. Error bars on the bar charts represent SD from two independent experiments. Scale bars, 10 µm.
